Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | RXRA | P19793 | 1/20 | 0.58 |
| ▸ | RXRB | P28702 | 1/20 | 0.58 |
| ▸ | RXRG | P48443 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 5/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | PTGER1 | P34995 | 5/20 | 0.51 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.51 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.51 |
| ▸ | PTGER2 | P43116 | 4/20 | 0.51 |
| ▸ | HTT | P42858 | 4/20 | 0.50 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.50 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13444685 | 0.86 | L3MBTL1 (0.64) | L3MBTL1TDP1RXRARXRBRXRG | |
| SCHEMBL7873889 | 0.83 | PTPN1 (0.61) | L3MBTL1TDP1LMNAMAPK1ALDH1A1 | |
| SCHEMBL13444680 | 0.83 | L3MBTL1 (0.60) | L3MBTL1TDP1LMNAMAPK1ALDH1A1 | |
| SCHEMBL8015222 | 0.83 | L3MBTL1 (0.57) | L3MBTL1TDP1LMNAMAPK1ALDH1A1 | |
| SCHEMBL23447516 | 0.80 | SMN1; SMN2 (0.68) | L3MBTL1RXRARXRBRXRGMAPK1 | |
| SCHEMBL31441164 | 0.80 | HTT (0.59) | L3MBTL1TDP1MAPK1MCL1ALDH1A1 | |
| SCHEMBL14327977 | 0.80 | L3MBTL1 (0.64) | L3MBTL1TDP1LMNAMAPK1ALDH1A1 | |
| Acetic Acid SCHEMBL5690407 | 0.80 | RXRA (0.72) | L3MBTL1TDP1RXRARXRBRXRG | |
| SCHEMBL1947848 | 0.79 | L3MBTL1 (0.72) | L3MBTL1TDP1RXRARXRBRXRG | |
| SCHEMBL13444686 | 0.78 | ALDH1A1 (0.56) | L3MBTL1TDP1LMNAMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007001335-A2 | RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. (US) | 2007-01-04 | — | — | WO | disclosed |
| US-20060211603-A1 | Ramoplanin derivatives possessing antibacterial activity | VICURON PHARMACEUTICALS INC. (US) | 2006-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211603-A1 | Ramoplanin derivatives possessing antibacterial activity | CLSPN, LMAN2, RPN2 | L3MBTL1 2280/4885TDP1 2633/4885RXRA 3762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.